Comprehensive Prognostic and Predictive Molecular Subgroup Analysis within the High-risk Treatment Arms of NRG Oncology/RTOG 9802: a Phase III Trial of RT versus RT plus PCV in High-risk Low-grade Gliomas Other Scholarly Work

cited authors

  • Bell, EH; Won, M; Fleming, J; Becker, A; McElroy, J; Shaw, EG; Mehta, MP; Brachman, DG; Gertler, S; Murtha, AD; Schultz, CJ; Johnson, D; Laack, NN; Hunter, GK; Crocker, IR; Chakravarti, A

sustainable development goals

authors

publication date

  • September 1, 2019

webpage

published in

keywords

  • Life Sciences & Biomedicine
  • Oncology
  • Radiology, Nuclear Medicine & Medical Imaging
  • Science & Technology

WoS ID

  • 000485671502572

Digital Object Identifier (DOI)

start page

  • S78

end page

  • S79

volume

  • 105

issue

  • 1

international collaboration

  • true